The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10x Genomics, Inc. | CL A COM | 88025u109 | 20,120,642 | 359,554 | SH | SOLE | 359,554 | 0 | 0 | |||
| Aadi Bioscience, Inc. | COM | 00032Q104 | 1,063,185 | 526,329 | SH | SOLE | 526,329 | 0 | 0 | |||
| ACELYRIN INC(NSM) | COM | 00445A100 | 10,227,294 | 1,370,951 | SH | SOLE | 1,370,951 | 0 | 0 | |||
| Alpine Immune Sciences, Inc. | COM | 02083G100 | 135,007,469 | 7,083,288 | SH | SOLE | 7,083,288 | 0 | 0 | |||
| Arcus Biosciences, Inc | COM | 03969F109 | 16,612,989 | 869,790 | SH | SOLE | 869,790 | 0 | 0 | |||
| Argenx SE | SHS | 04016x101 | 10,434,814 | 27,429 | SH | SOLE | 27,429 | 0 | 0 | |||
| AtriCure Inc. | COM | 04963C209 | 1,650,984 | 46,259 | SH | SOLE | 46,259 | 0 | 0 | |||
| Aura Biosciences, Inc. | COM | 05153U107 | 4,567,817 | 515,555 | SH | SOLE | 515,555 | 0 | 0 | |||
| BeyondSpring Inc. | SHS | G10830100 | 4,450,329 | 4,958,143 | SH | SOLE | 4,958,143 | 0 | 0 | |||
| Cue Health Inc. | COM | 229790100 | 1,459,398 | 8,980,909 | SH | SOLE | 8,980,909 | 0 | 0 | |||
| Equillium Inc. | COM | 29446K106 | 3,215,403 | 4,447,308 | SH | SOLE | 4,447,308 | 0 | 0 | |||
| GeneDx Holdings Corp. | COM CL A | 81663L200 | 284,911 | 103,604 | SH | SOLE | 103,604 | 0 | 0 | |||
| Illumnia, Inc. | COM | 452327109 | 11,258,807 | 80,859 | SH | SOLE | 80,859 | 0 | 0 | |||
| IMMUNOGEN INC | COM | 45253H101 | 19,566,865 | 659,928 | SH | SOLE | 659,928 | 0 | 0 | |||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 14,875,970 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | |||
| KRYSTAL BIOTECH INC | COM | 501147102 | 8,159,674 | 65,772 | SH | SOLE | 65,772 | 0 | 0 | |||
| LANTHEUS HOLDINGS INC(NMS) | COM | 516544103 | 5,716,152 | 92,196 | SH | SOLE | 92,196 | 0 | 0 | |||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | 28,844,941 | 2,940,361 | SH | SOLE | 2,940,361 | 0 | 0 | |||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 7,760,500 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | |||
| Pyxis Oncology, Inc (formerly Apexigen) | COM | 747324101 | 588,258 | 326,810 | SH | SOLE | 326,810 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | COM | G76279101 | 14,371,031 | 1,279,700 | SH | SOLE | 1,279,700 | 0 | 0 | |||
| Scynexis Inc. | COM NEW | 811292200 | 1,238,888 | 555,555 | SH | SOLE | 555,555 | 0 | 0 | |||
| Terns Pharmaceuticals, Inc. | COM | 880881107 | 4,635,710 | 714,285 | SH | SOLE | 714,285 | 0 | 0 | |||
| Zentalis Pharmaceuticals Inc. | COM | 98943L107 | 31,808,682 | 2,099,583 | SH | SOLE | 2,099,583 | 0 | 0 | |||